OMERS ADMINISTRATION Corp Acquires Shares of 109,400 Rapid Micro Biosystems, Inc. $RPID

Key Points

• OMERS ADMINISTRATION Corp acquired a new stake in Rapid Micro Biosystems, purchasing 109,400 shares valued at approximately $289,000, representing about 0.25% of the company.
• Wall Street analysts have expressed mixed views on Rapid Micro Biosystems, with one analyst downgrading the stock from a "hold" to a "sell" and another setting a "buy" rating with an $8.00 price target.
• After reporting earnings that missed consensus estimates, Rapid Micro Biosystems' stock has experienced fluctuations, currently trading at $2.38 with a market cap of $105.22 million.

OMERS ADMINISTRATION Corp acquired a new position in shares of Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Free Report) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 109,400 shares of the company's stock, valued at approximately $289,000. OMERS ADMINISTRATION Corp owned approximately 0.25% of Rapid Micro Biosystems as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Millennium Management LLC raised its position in shares of Rapid Micro Biosystems by 17.6% during the 4th quarter. Millennium Management LLC now owns 61,375 shares of the company's stock valued at $55,000 after buying an additional 9,191 shares in the last quarter. Citadel Advisors LLC bought a new position in shares of Rapid Micro Biosystems during the 4th quarter valued at approximately $65,000. Renaissance Technologies LLC lifted its holdings in shares of Rapid Micro Biosystems by 122.9% in the 4th quarter. Renaissance Technologies LLC now owns 183,087 shares of the company's stock worth $165,000 after buying an additional 100,942 shares during the period. Evernest Financial Advisors LLC acquired a new position in Rapid Micro Biosystems during the 1st quarter valued at about $347,000. Finally, Informed Momentum Co LLC acquired a new stake in Rapid Micro Biosystems during the first quarter worth about $467,000. Institutional investors and hedge funds own 52.60% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently commented on RPID shares. Wall Street Zen lowered shares of Rapid Micro Biosystems from a "hold" rating to a "sell" rating in a research note on Friday, August 22nd. Lake Street Capital assumed coverage on Rapid Micro Biosystems in a report on Monday, July 28th. They issued a "buy" rating and a $8.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Strong Buy" and an average price target of $8.00.

Rapid Micro Biosystems Trading Down 0.6%

RPID traded down $0.02 during trading on Monday, hitting $2.71. 28,393 shares of the company traded hands, compared to its average volume of 263,950. Rapid Micro Biosystems, Inc. has a 1 year low of $0.80 and a 1 year high of $4.50. The company has a market cap of $119.59 million, a PE ratio of -2.69 and a beta of 1.30. The stock's 50-day simple moving average is $3.18 and its two-hundred day simple moving average is $2.93.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last issued its quarterly earnings data on Tuesday, August 12th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.01). The firm had revenue of $7.26 million during the quarter, compared to analysts' expectations of $7.10 million. Rapid Micro Biosystems had a negative return on equity of 63.07% and a negative net margin of 145.63%. Rapid Micro Biosystems has set its FY 2025 guidance at EPS. Equities analysts expect that Rapid Micro Biosystems, Inc. will post -1.1 EPS for the current year.

Insider Buying and Selling at Rapid Micro Biosystems

In other news, CEO Robert G. Jr. Spignesi sold 11,881 shares of the stock in a transaction that occurred on Monday, July 14th. The shares were sold at an average price of $3.32, for a total transaction of $39,444.92. Following the sale, the chief executive officer directly owned 970,550 shares of the company's stock, valued at $3,222,226. This represents a 1.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Over the last quarter, insiders sold 57,443 shares of company stock worth $195,952. 29.96% of the stock is currently owned by company insiders.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.